semaglutide prediabetes progression to type 2 diabetes trial Efficacy and safety of once-weekly 2·4 mg versus placebo in people with obesity and (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 semaglutide prediabetes progression to type
Pay in 4 interest-free payments of $5.95 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12















![Celebi (16/64) [Neo Revelation Unlimited] SM217](https://cdn.shopify.com/s/files/1/0518/7613/5111/products/a543588b-cab3-4a1f-b7f9-700bba5e40c0.jpg?v=1696325586)

![Grovyle (7/17) [POP Series 4] 188](https://cdn.shopify.com/s/files/1/0518/7613/5111/products/f23966e1-0029-4c6d-ac10-380303cb4a5f.png?v=1696324775)

